SPC
GNOM icon

Sigma Planning Corp’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History

Sigma Planning Corp’s Portfolio GNOM Stock Details GNOM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-4,574
Closed -$455K – 1426
2021
Q2 		$455K Buy
+4,574
New +$406K 0.01% 871

Other funds holding GNOM

Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $299B AUM 28.69% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.3B AUM 22.13% 1-Year Est. Return
MIG
McGuire Investment Group Wakefield, Rhode Island $885M AUM 47.78% 1-Year Est. Return
CW
CreativeOne Wealth Overland Park, Kansas $4.31B AUM 19.42% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
SFS
Sowell Financial Services North Little Rock, Arkansas $3.06B AUM 30.02% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Sigma Planning Corp's GNOM Position: Q3 2021 in Review

Sigma Planning Corp sold out of Global X Genomics & Biotechnology ETF (GNOM) in Q3 2021, closing a stake of 4,574 shares — an estimated $455K sold.

Sigma Planning Corp first reported a position in GNOM in Q2 2021 and held it in 1 quarter. The position peaked at $455K in Q2 2021. 54 funds tracked by Wall St. Rank hold GNOM as of Q3 2021.

  • Sigma Planning Corp reported no remaining Global X Genomics & Biotechnology ETF position as of Q3 2021 after selling out during the quarter.
  • Sigma Planning Corp sold 4,574 Global X Genomics & Biotechnology ETF shares in Q3 2021, an estimated $455K.
  • Sigma Planning Corp first reported a position in Global X Genomics & Biotechnology ETF in Q2 2021 and held it in 1 quarter.
  • Sigma Planning Corp's Global X Genomics & Biotechnology ETF position peaked at $455K in Q2 2021.
  • 54 funds tracked by Wall St. Rank held Global X Genomics & Biotechnology ETF as of Q3 2021.

Based on Sigma Planning Corp's 13F filing for Q3 2021, filed 28 Oct 2021.